Corcept Therapeutics Inc (CORT):企業の財務・戦略的SWOT分析

◆英語タイトル:Corcept Therapeutics Inc (CORT) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH63419FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年3月
◆ページ数:51
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Corcept Therapeutics Inc (CORT) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Corcept Therapeutics Inc (Corcept) discovers, develops and commercializes innovative therapeutics in the areas of psychiatric and metabolic diseases. The company’s marketed product, Korlym (mifepristone) a cortisol receptor blocker indicated to control hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing’s syndrome. Corcept’s major pipeline products include relacorilant for endogenous cushing syndrome; miricorilant for NASH and antipsychotic-induced weight gain. It also has pipeline products in different phases of clinical trials indicated for treatment of pancreatic cancer, ovarian cancer, adrenocortical cancer, amyotrophic lateral sclerosis, alcohol use disorder and post-traumatic stress disorder among other disorders. Corcept is headquartered in Menlo Park, California, the US.

Corcept Therapeutics Inc Key Recent Developments

Mar 01,2021: Corcept Therapeutics expands executive team; Atabak Mokari joins as Chief Financial Officer; Charles Robb named Chief Business Officer
Feb 23,2021: Corcept Therapeutics announces fourth quarter and full-year 2020 audited financial results
Feb 08,2021: Corcept Therapeutics announces fourth quarter, full-year 2020 preliminary selected financial results and 2021 revenue guidance; Provides corporate update
Nov 23,2020: Corcept Therapeutics appoints Gillian M. Cannon, PhD, to Board of Directors
Nov 03,2020: Corcept Therapeutics announces third quarter 2020 financial results and provides corporate update

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Corcept Therapeutics Inc – Key Facts
Corcept Therapeutics Inc – Key Employees
Corcept Therapeutics Inc – Key Employee Biographies
Corcept Therapeutics Inc – Major Products and Services
Corcept Therapeutics Inc – History
Corcept Therapeutics Inc – Company Statement
Corcept Therapeutics Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Corcept Therapeutics Inc – Business Description
Corcept Therapeutics Inc – SWOT Analysis
SWOT Analysis – Overview
Corcept Therapeutics Inc – Strengths
Corcept Therapeutics Inc – Weaknesses
Corcept Therapeutics Inc – Opportunities
Corcept Therapeutics Inc – Threats
Corcept Therapeutics Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Corcept Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Corcept Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Corcept Therapeutics Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 01, 2021: Corcept Therapeutics expands executive team; Atabak Mokari joins as Chief Financial Officer; Charles Robb named Chief Business Officer
Feb 23, 2021: Corcept Therapeutics announces fourth quarter and full-year 2020 audited financial results
Feb 08, 2021: Corcept Therapeutics announces fourth quarter, full-year 2020 preliminary selected financial results and 2021 revenue guidance; Provides corporate update
Nov 23, 2020: Corcept Therapeutics appoints Gillian M. Cannon, PhD, to Board of Directors
Nov 03, 2020: Corcept Therapeutics announces third quarter 2020 financial results and provides corporate update
Aug 04, 2020: Corcept Therapeutics announces second quarter 2020 financial results and provides corporate update
Jul 14, 2020: Corcept Therapeutics: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers
May 04, 2020: Corcept Therapeutics announces first quarter 2020 financial results and provides corporate update
Mar 12, 2020: Corcept Therapeutics appoints Gregg Alton to Board of Directors
Feb 20, 2020: Corcept Therapeutics announces fourth quarter And full-year 2019 audited financial results and provides corporate update
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Corcept Therapeutics Inc, Key Facts
Corcept Therapeutics Inc, Key Employees
Corcept Therapeutics Inc, Key Employee Biographies
Corcept Therapeutics Inc, Major Products and Services
Corcept Therapeutics Inc, History
Corcept Therapeutics Inc, Subsidiaries
Corcept Therapeutics Inc, Key Competitors
Corcept Therapeutics Inc, Ratios based on current share price
Corcept Therapeutics Inc, Annual Ratios
Corcept Therapeutics Inc, Annual Ratios (Cont...1)
Corcept Therapeutics Inc, Annual Ratios (Cont...2)
Corcept Therapeutics Inc, Interim Ratios
Corcept Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Corcept Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Corcept Therapeutics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Corcept Therapeutics Inc (CORT):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Inovise Medical, Inc.-医療機器分野:企業M&A・提携分析
    Summary Inovise Medical, Inc. (Inovise Medical) is a diagnostic medical technology company that develops technology for diagnosing and monitoring heart disease. The company offers cardiovascular monitoring devices, ECG monitoring equipment. Its product portfolio includes AUDICOR AM monitor, AUDICOR …
  • Actinogen Medical Ltd (ACW):企業の財務・戦略的SWOT分析
    Summary Actinogen Medical Ltd (Actinogen), formerly Actinogen Ltd is a biotechnology company that develops novel treatments for alzheimer’s disease and the cognitive decline associated with neurodegenerative diseases and metabolic diseases. The company’s xanamem is a novel drug under development for …
  • Asklepios BioPharmaceutical Inc-製薬・医療分野:企業M&A・提携分析
    Summary Asklepios Biopharmaceutical Inc (AskBio) is a biotechnology company that develops and markets novel protein and cellular based therapies. The company has developed library of rAAV biological nano particles that provides unsurpassed transduction. Its products include such as biostrophin, AskB …
  • Seagate Technology Public Limited Company:企業のM&A・事業提携・投資動向
    Seagate Technology Public Limited Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Seagate Technology Public Limited Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detaile …
  • Kwality Group:企業の戦略・SWOT・財務分析
    Kwality Group - Strategy, SWOT and Corporate Finance Report Summary Kwality Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Laboratory Corporation of America Holdings:企業の戦略・SWOT・財務分析
    Laboratory Corporation of America Holdings - Strategy, SWOT and Corporate Finance Report Summary Laboratory Corporation of America Holdings - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Belden Inc (BDC):企業の財務・戦略的SWOT分析
    Belden Inc (BDC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • FirstCaribbean International Bank Limited:企業の戦略的SWOT分析
    FirstCaribbean International Bank Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Central Bank of Egypt:企業の戦略的SWOT分析
    Central Bank of Egypt - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Sumitomo Rubber Industries Ltd (5110):企業の財務・戦略的SWOT分析
    Sumitomo Rubber Industries Ltd (5110) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • CryoPort Inc (CYRX):企業の財務・戦略的SWOT分析
    CryoPort Inc (CYRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Dataprep Holdings Bhd (DATAPRP):企業の財務・戦略的SWOT分析
    Dataprep Holdings Bhd (DATAPRP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Ipsos SA (IPS):企業の財務・戦略的SWOT分析
    Ipsos SA (IPS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Indivumed GmbH:医療機器:M&Aディール及び事業提携情報
    Summary Indivumed GmbH (Indivumed) is an oncology company that provides solutions for diagnosis and treatment of cancer. The company is involved in the generation, characterization, and analysis of biologic samples from human cancer patients. It offers biospecimen products and clinical data sets; an …
  • Marina Biotech, Inc.:企業の戦略・SWOT・財務情報
    Marina Biotech, Inc. - Strategy, SWOT and Corporate Finance Report Summary Marina Biotech, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • China Life Insurance Co Ltd:戦略・SWOT・企業財務分析
    China Life Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report Summary China Life Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Old Dominion Freight Line Inc (ODFL):企業の財務・戦略的SWOT分析
    Old Dominion Freight Line Inc (ODFL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • La-Z-Boy Incorporated:企業の戦略・SWOT・財務分析
    La-Z-Boy Incorporated - Strategy, SWOT and Corporate Finance Report Summary La-Z-Boy Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Topcon Corp (7732)-医療機器分野:企業M&A・提携分析
    Summary Topcon Corp (Topcon) is a medical device company that offers positioning and smart infrastructure and eye care products. The company provides positioning and smart infrastructure products which include TOCON and SOKKIA products. Topcon offers GNSS, total station, 3D scanner, machine control, …
  • Nitto Denko Corp (6988):企業の財務・戦略的SWOT分析
    Nitto Denko Corp (6988) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆